SELLAS Life Sciences (SLS) EBIT Margin (QoQ) (2012 - 2021)
SELLAS Life Sciences (SLS) EBIT Margin (QoQ) (2012 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -19,498.00 |
| Mar 31, 2021 | 17,951.00 |
| Jun 30, 2015 | 5,550.00 |
| Mar 31, 2015 | -2,069.00 |
| Dec 31, 2014 | 34,890.00 |
| Sep 30, 2014 | 2,481.00 |
| Jun 30, 2014 | -13,181.00 |
| Mar 31, 2014 | -32,622.00 |
| Dec 31, 2013 | 20,643.00 |
| Sep 30, 2013 | -8,289.00 |
| Jun 30, 2013 | -3,837.00 |
| Mar 31, 2013 | -78,099.00 |
| Dec 31, 2012 | 94,923.00 |